Current Allergy and Asthma Reports

, Volume 13, Issue 5, pp 453–461

Asthma Microbiome Studies and the Potential for New Therapeutic Strategies



Recent applications of culture-independent tools for microbiome profiling have revealed significant relationships between asthma and microbiota associated with the environment, gut, or airways. Studies of the airway microbiome in particular represent a new frontier in pulmonary research. Although these studies are relatively new, current evidence suggests the possibility of new therapeutic strategies for the treatment or prevention of asthma. In this article, recent literature on microbiota and asthma are critically reviewed, with a particular focus on studies of the airway microbiome. Perspectives are presented on how growing knowledge of relationships between the microbiome and asthma is likely to translate into improved understanding of asthma pathogenesis, its heterogeneity, and opportunities for novel treatment approaches.


Asthma Microbiome 16S ribosomal RNA Microarray Sequencing Therapy Respiratory microbiota Treatment-resistant asthma 


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Ownby DR, Johnson CC, Peterson EL. Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. JAMA. 2002;288(8):963–72.PubMedCrossRefGoogle Scholar
  2. 2.
    Kalliomaki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol. 2001;107:129–34.PubMedCrossRefGoogle Scholar
  3. 3.
    Havstad S, Wegienka G, Zoratti EM, et al. Effect of prenatal indoor pet exposure on the trajectory of total IgE levels in early childhood. J Allergy Clin Immunol. 2011;128:880–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Braun-Fahrländer C, Riedler J, Herz U, et al. Allergy and endotoxin study team. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med. 2002;347(12):869–77.PubMedCrossRefGoogle Scholar
  5. 5.
    Ege MJ, Mayer M, Normand AC, et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med. 2011;364(8):701–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Bisgaard H, Li N, Bonnelykke K, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol. 2011;128(3):646–52.e1-5.PubMedCrossRefGoogle Scholar
  7. 7.
    Martin RJ, Kraft M, Chu HW, et al. A link between chronic asthma and chronic infection. J Allergy Clin Immunol. 2001;107(4):595–601.PubMedCrossRefGoogle Scholar
  8. 8.
    Kocabas A, Avsar M, Hanta I, et al. Chlamydophila pneumoniae infection in adult asthmatics patients. J Asthma. 2008;45(1):39–43.PubMedCrossRefGoogle Scholar
  9. 9.
    Specjalski K, Jassem E. Chlamydophila pneumoniae, Mycoplasma pneumoniae infections, and asthma control. Allergy Asthma Proc. 2011;32(2):9–17.PubMedCrossRefGoogle Scholar
  10. 10.
    Bisgaard H, Hermansen MN, Buchvald F, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med. 2007;357(15):1487–95.PubMedCrossRefGoogle Scholar
  11. 11.
    Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS One. 2010;5(1):e8578.PubMedCrossRefGoogle Scholar
  12. 12.
    • Huang YJ, Nelson CE, Brodie EL, et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol. 2011;127:372–381.e1–e3. This paper is the first to describe relationships between bacterial airway microbiota composition and clinical features of asthma, including airway hyperreactivity and response to prolonged clarithromycin therapy.PubMedCrossRefGoogle Scholar
  13. 13.
    Sogin ML, Morrison HG, Huber JA, et al. Microbial diversity in the deep sea and the underexplored "rare biosphere". Proc Natl Acad Sci USA. 2006;103(32):12115–20.PubMedCrossRefGoogle Scholar
  14. 14.
    Human Microbiome Jumpstart Reference Strains Consortium, Nelson KE, Weinstock GM, Highlander SK, et al. A catalog of reference genomes from the human microbiome. Science. 2010;328(5981):994–9.PubMedCrossRefGoogle Scholar
  15. 15.
    • Heederik D, von Mutius E. Does diversity of environmental microbial exposure matter for the occurrence of allergy and asthma? J Allergy Clin Immunol. 2012;130(1):44–50. This review provides an excellent summary of recent environmental microbiome studies in asthma.PubMedCrossRefGoogle Scholar
  16. 16.
    Ouwehand AC, Isolauri E, He F, et al. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol. 2001;108:144–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Vael C, Nelen V, Verhulst SL, et al. Early intestinal Bacteroides fragilis colonisation and development of asthma. BMC Pulm Med. 2008;8:19.PubMedCrossRefGoogle Scholar
  18. 18.
    Rogers GB, Carroll MP, Serisier DJ, et al. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16 s ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol. 2004;42(11):5176–83.PubMedCrossRefGoogle Scholar
  19. 19.
    Harris JK, De Groote MA, Sagel SD, et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci USA. 2007;104(51):20529–33.PubMedCrossRefGoogle Scholar
  20. 20.
    • Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med. 2011;184:957.e63. This study of lung microbiota in healthy subjects using detailed sampling procedures addresses issues of oral and environmental sources of contamination in lung microbiome studies.CrossRefGoogle Scholar
  21. 21.
    Huang YJ, Kim E, Cox MJ, et al. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS. 2010;14(1):9–59.PubMedCrossRefGoogle Scholar
  22. 22.
    Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the ‘healthy’ smoker and in COPD. PLoS One. 2011;6(2):e16384.PubMedCrossRefGoogle Scholar
  23. 23.
    Abt MC, Artis D. The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis. Curr Opin Gastroenterol. 2009;25(6):496–502.PubMedCrossRefGoogle Scholar
  24. 24.
    Fujimura KE, Slusher NA, Cabana MD, et al. Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther. 2010;8(4):435–54.PubMedCrossRefGoogle Scholar
  25. 25.
    • McLoughlin RM, Mills KH. Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J Allergy Clin Immunol. 2011;127:1097–107. This article provides an excellent summary of immunomodulatory effects of gut microbiota and their potential role in the development of allergy and asthma.PubMedCrossRefGoogle Scholar
  26. 26.
    Kozyrskyj AL, Bahreinian S, Azad MB. Early life exposures: impact on asthma and allergic disease. Curr Opin Allergy Clin Immunol. 2011;11(5):400–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Brodie EL, Desantis TZ, Joyner DC, et al. Application of a high-density oligonucleotide microarray approach to study bacterial population dynamics during uranium reduction and reoxidation. Appl Environ Microbiol. 2006;72:6288e98.CrossRefGoogle Scholar
  28. 28.
    DeSantis TZ, Brodie EL, Moberg JP, et al. High-density universal 16S rRNA microarray analysis reveals broader diversity than typical clone library when sampling the environment. Microb Ecol. 2007;53:371e83.CrossRefGoogle Scholar
  29. 29.
    Rajilić-Stojanović M, Heilig HG, Molenaar D, et al. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol. 2009;11(7):1736–51.PubMedCrossRefGoogle Scholar
  30. 30.
    • Hazen TC, Dubinsky EA, DeSantis TZ, et al. Deep-sea oil plume enriches indigenous oil-degrading bacteria. Science. 2010;330(6001):204–8. This article includes detailed description of a new generation 16S rRNA-based microarray platform and its deep profiling capabilities for bacterial microbiome studies.PubMedCrossRefGoogle Scholar
  31. 31.
    Hamady M, Knight R. Microbial community profiling for human microbiome projects: tools, techniques, and challenges. Genome Res. 2009;19:1141e52.CrossRefGoogle Scholar
  32. 32.
    • Han MK, Huang YJ, Lipuma JJ, et al. Significance of the microbiome in obstructive lung disease. Thorax. 2012;67(5):456–63. This review summarizes recent lung microbiome studies of different diseases including an overview of molecular techniques for microbiome profiling.PubMedCrossRefGoogle Scholar
  33. 33.
    • Loman NJ, Constantinidou C, Chan JZ, et al. High-throughput bacterial genome sequencing: an embarrassment of choice, a world of opportunity. Nat Rev Microbiol. 2012;10(9):599–606. An excellent summary of next-generation sequencing technologies for microbial genome sequencing with discussion of related considerations and challenges.PubMedCrossRefGoogle Scholar
  34. 34.
    • Yuan S, Cohen DB, Ravel J, et al. Evaluation of methods for the extraction and purification of DNA from the human microbiome. PLoS One. 2012;7(3):e33865. This study highlights the effects of different sample extraction methods on bacterial community characterization by next-generation sequencing.PubMedCrossRefGoogle Scholar
  35. 35.
    Soergel DA, Dey N, Knight R, et al. Selection of primers for optimal taxonomic classification of environmental 16S rRNA gene sequences. ISME J. 2012;6(7):1440–4.PubMedCrossRefGoogle Scholar
  36. 36.
    • Kumar PS, Brooker MR, Dowd SE, et al. Target region selection is a critical determinant of community fingerprints generated by 16S pyrosequencing. PLoS One. 2011;6(6):e20956. This study discusses differences in bacterial community profiles generated by pyrosequencing using primers targeting different hypervariable regions of the 16S rRNA.PubMedCrossRefGoogle Scholar
  37. 37.
    Ege MJ, Mayer M, Schwaiger K, et al. Environmental bacteria and childhood asthma. Allergy. 2012;67(12):1565–71.PubMedGoogle Scholar
  38. 38.
    Loss G, Apprich S, Waser M, et al. The protective effect of farm milk consumption on childhood asthma and atopy: the GABRIELA study. J Allergy Clin Immunol. 2011;128:766–773 e4.PubMedCrossRefGoogle Scholar
  39. 39.
    Stensballe LG, Simonsen J, Jensen SM, et al. Use of antibiotics during pregnancy increases the risk of asthma in early childhood. J Pediatr. 2013;162(4):832–838.e3.PubMedCrossRefGoogle Scholar
  40. 40.
    Lodge CJ, Allen KJ, Lowe AJ, et al. Perinatal cat and dog exposure and the risk of asthma and allergy in the urban environment: a systematic review of longitudinal studies. Clin Dev Immunol. 2012;2012:176484.PubMedCrossRefGoogle Scholar
  41. 41.
    Lødrup Carlsen KC, Roll S, et al. Does pet ownership in infancy lead to asthma or allergy at school age? Pooled analysis of individual participant data from 11 European birth cohorts. PLoS One. 2012;7(8):e43214.PubMedCrossRefGoogle Scholar
  42. 42.
    Penders J, Kummeling I, Thijs C. Infant antibiotic use and wheeze and asthma risk: a systematic review and meta-analysis. Eur Respir J. 2011;38(2):295–302.PubMedCrossRefGoogle Scholar
  43. 43.
    Michel S, Busato F, Genuneit J, et al. Farm exposure and time trends in early childhood may influence DNA methylation in genes related to asthma and allergy. Allergy. 2013;68(3):355–64.PubMedCrossRefGoogle Scholar
  44. 44.
    • Round JL, O'Connell RM, Mazmanian SK. Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun. 2010;34(3):J220–5. This review provides an excellent summary of immune tolerance mechanisms induced by microbiota.PubMedCrossRefGoogle Scholar
  45. 45.
    Mileti E, Matteoli G, Iliev ID, et al. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One. 2009;4(9):e7056.PubMedCrossRefGoogle Scholar
  46. 46.
    Olszak T, An D, Zeissig S, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012;336(6080):489–93.PubMedCrossRefGoogle Scholar
  47. 47.
    Herbst T, Sichelstiel A, Schär C, Yadava K, Bürki K, Cahenzli J, et al. Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am J Respir Crit Care Med. 2011;184(2):198–205.PubMedCrossRefGoogle Scholar
  48. 48.
    Russell SL, Gold MJ, Hartmann M, et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012;13(5):440–7.PubMedCrossRefGoogle Scholar
  49. 49.
    Karimi K, Inman MD, Bienenstock J, et al. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med. 2009;179:186–93.PubMedCrossRefGoogle Scholar
  50. 50.
    MacSharry J, O'Mahony C, Shalaby KH, et al. Immunomodulatory effects of feeding with Bifidobacterium longum on allergen-induced lung inflammation in the mouse. Pulm Pharmacol Ther. 2012;25(4):325–34.PubMedCrossRefGoogle Scholar
  51. 51.
    Harb H, van Tol EA, Heine H, et al. Neonatal supplementation of processed supernatant from Lactobacillus rhamnosus GG improves allergic airway inflammation in mice later in life. Clin Exp Allergy. 2013;43(3):353–64.PubMedCrossRefGoogle Scholar
  52. 52.
    Zhang B, An J, Shimada T, Liu S, et al. Oral administration of Enterococcus faecalis FK-23 suppresses Th17 cell development and attenuates allergic airway responses in mice. Int J Mol Med. 2012;30(2):248–54.PubMedGoogle Scholar
  53. 53.
    Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA. 1991;266(2):225–30.PubMedCrossRefGoogle Scholar
  54. 54.
    Yano T, Ichikawa Y, Komatu S, Arai S, Oizumi K. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am J Respir Crit Care Med. 1994;149(5):1348–53.PubMedCrossRefGoogle Scholar
  55. 55.
    Ten Brinke A, Van Dissel JT, Sterk PJ, et al. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol. 2001;107(3):449–54.PubMedCrossRefGoogle Scholar
  56. 56.
    Johnston SL, Martin RJ. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med. 2005;172(9):1078–89.PubMedCrossRefGoogle Scholar
  57. 57.
    Metz G, Kraft M. Effects of atypical infections with Mycoplasma and Chlamydia on asthma. Immunol Allergy Clin North Am. 2010;30(4):575–85. vii-viii.PubMedCrossRefGoogle Scholar
  58. 58.
    Hong SJ. The role of Mycoplasma pneumoniae infection in asthma. Allergy Asthma Immunol Res. 2012;4(2):59–61.PubMedCrossRefGoogle Scholar
  59. 59.
    Bisgaard H, Hermansen MN, Bonnelykke K, et al. Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study. BMJ. 2010;341:c4978.PubMedCrossRefGoogle Scholar
  60. 60.
    Marri PR, Stern DA, Wright AL, et al. Asthma-associated differences in microbial composition of induced sputum. J Allergy Clin Immunol. 2013;131(2):346–352.e3.PubMedCrossRefGoogle Scholar
  61. 61.
    DeSantis TZ, Brodie EL, Moberg JP, et al. High-density universal 16S rRNA microarray analysis reveals broader diversity than typical clone library when sampling the environment. Microb Ecol. 2007;53(3):371–83.PubMedCrossRefGoogle Scholar
  62. 62.
    van Woerden HC, Gregory C, Brown R, et al. Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. BMC Infect Dis. 2013;13:69.PubMedCrossRefGoogle Scholar
  63. 63.
    • Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716–25. This review discusses insights into asthma heterogeneity and phenotypes using combined clinical and molecular approaches to patient characterization.PubMedCrossRefGoogle Scholar
  64. 64.
    Rauch M, Lynch SV. The potential for probiotic manipulation of the gastrointestinal microbiome. Curr Opin Biotechnol. 2012;23(2):192–201.PubMedCrossRefGoogle Scholar
  65. 65.
    • Essilfie AT, Simpson JL, Horvat JC, et al. Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLoS Pathog. 2011;7(10):e1002244. Interesting murine study showing modulation of eosinophilic allergic airway inflammation and asthma responses by acute infection with Haemophilus influenzae.PubMedCrossRefGoogle Scholar
  66. 66.
    • Essilfie AT, Simpson JL, Dunkley ML, et al. Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax. 2012;67:588–99. Followup to previous study showing corticosteroid-resistant nature of inflammation resulting from H. influenzae-induced modulation of allergic airway disease.PubMedCrossRefGoogle Scholar
  67. 67.
    Larsen JM, Steen-Jensen DB, Laursen JM, et al. Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLoS One. 2012;7(2):e31976.PubMedCrossRefGoogle Scholar
  68. 68.
    Kinross JM, Darzi AW, Nicholson JK. Gut microbiome-host interactions in health and disease. Genome Med. 2011;3(3):14.PubMedCrossRefGoogle Scholar
  69. 69.
    Henriksson G, Helgeland L, Midtvedt T, et al. Immune response to Mycoplasma pulmonis in nasal mucosa is modulated by the normal microbiota. Am J Respir Cell Mol Biol. 2004;31(6):657–62.PubMedCrossRefGoogle Scholar
  70. 70.
    Ichinohe T, Pang IK, Kumamoto Y, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA. 2011;108(13):5354–9.PubMedCrossRefGoogle Scholar
  71. 71.
    Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180(5):388–95.PubMedCrossRefGoogle Scholar
  72. 72.
    Wilson ID, Nicholson JK. The role of gut microbiota in drug response. Curr Pharm Des. 2009;15(13):1519–23.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Division of Pulmonary, Critical Care, Allergy, and Sleep MedicineUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations